These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 25413799

  • 1. TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance.
    Costa B, Da Pozzo E, Giacomelli C, Taliani S, Bendinelli S, Barresi E, Da Settimo F, Martini C.
    Apoptosis; 2015 Mar; 20(3):383-98. PubMed ID: 25413799
    [Abstract] [Full Text] [Related]

  • 2. Anxiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABAA receptor activity.
    Costa B, Da Pozzo E, Chelli B, Simola N, Morelli M, Luisi M, Maccheroni M, Taliani S, Simorini F, Da Settimo F, Martini C.
    Psychoneuroendocrinology; 2011 May; 36(4):463-72. PubMed ID: 20728278
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Computational studies on translocator protein (TSPO) and its ligands.
    Ortore G, Tuccinardi T, Martinelli A.
    Curr Top Med Chem; 2012 May; 12(4):352-9. PubMed ID: 22204485
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CoCl(2) induces apoptosis via the 18 kDa translocator protein in U118MG human glioblastoma cells.
    Zeno S, Zaaroor M, Leschiner S, Veenman L, Gavish M.
    Biochemistry; 2009 Jun 02; 48(21):4652-61. PubMed ID: 19358520
    [Abstract] [Full Text] [Related]

  • 8. Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells.
    Daniele S, Barresi E, Zappelli E, Marinelli L, Novellino E, Da Settimo F, Taliani S, Trincavelli ML, Martini C.
    Oncotarget; 2016 Feb 16; 7(7):7866-84. PubMed ID: 26761214
    [Abstract] [Full Text] [Related]

  • 9. The 18-kDa translocator protein, formerly known as the peripheral-type benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line.
    Shoukrun R, Veenman L, Shandalov Y, Leschiner S, Spanier I, Karry R, Katz Y, Weisinger G, Weizman A, Gavish M.
    Pharmacogenet Genomics; 2008 Nov 16; 18(11):977-88. PubMed ID: 18806692
    [Abstract] [Full Text] [Related]

  • 10. PK 11195 differentially affects cell survival in human wild-type and 18 kDa translocator protein-silenced ADF astrocytoma cells.
    Chelli B, Salvetti A, Da Pozzo E, Rechichi M, Spinetti F, Rossi L, Costa B, Lena A, Rainaldi G, Scatena F, Vanacore R, Gremigni V, Martini C.
    J Cell Biochem; 2008 Oct 15; 105(3):712-23. PubMed ID: 18668527
    [Abstract] [Full Text] [Related]

  • 11. Medicinal chemistry of indolylglyoxylamide TSPO high affinity ligands with anxiolytic-like effects.
    Simorini F, Marini AM, Taliani S, La Motta C, Salerno S, Pugliesi I, Da Settimo F.
    Curr Top Med Chem; 2012 Oct 15; 12(4):333-51. PubMed ID: 22204487
    [Abstract] [Full Text] [Related]

  • 12. Structure-activity relationship refinement and further assessment of 4-phenylquinazoline-2-carboxamide translocator protein ligands as antiproliferative agents in human glioblastoma tumors.
    Castellano S, Taliani S, Viviano M, Milite C, Da Pozzo E, Costa B, Barresi E, Bruno A, Cosconati S, Marinelli L, Greco G, Novellino E, Sbardella G, Da Settimo F, Martini C.
    J Med Chem; 2014 Mar 27; 57(6):2413-28. PubMed ID: 24580635
    [Abstract] [Full Text] [Related]

  • 13. Apoptosis therapy in cancer: the first single-molecule co-activating p53 and the translocator protein in glioblastoma.
    Daniele S, Taliani S, Da Pozzo E, Giacomelli C, Costa B, Trincavelli ML, Rossi L, La Pietra V, Barresi E, Carotenuto A, Limatola A, Lamberti A, Marinelli L, Novellino E, Da Settimo F, Martini C.
    Sci Rep; 2014 Apr 23; 4():4749. PubMed ID: 24756113
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) Ligands.
    Taliani S, Pugliesi I, Da Settimo F.
    Curr Top Med Chem; 2011 Apr 23; 11(7):860-86. PubMed ID: 21291396
    [Abstract] [Full Text] [Related]

  • 18. Translocator protein as a promising target for novel anxiolytics.
    Costa B, Da Pozzo E, Martini C.
    Curr Top Med Chem; 2012 Apr 23; 12(4):270-85. PubMed ID: 22204481
    [Abstract] [Full Text] [Related]

  • 19. Derivatives of the pyrazolo[1,5-a]pyrimidine acetamide DPA-713 as translocator protein (TSPO) ligands and pro-apoptotic agents in human glioblastoma.
    Werry EL, King VA, Barron ML, Banister SD, Sokias R, Kassiou M.
    Eur J Pharm Sci; 2017 Jan 01; 96():186-192. PubMed ID: 27658888
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.